Biotech
Sana Biotechnology
Sana Biotechnology raises $700M IPO at $4.2B valuation
$700M
Total Raised
IPO
Latest Round
2018
Founded
400+
Employees
188 East Blaine Street, Seattle, WA 98102
1 min read
Quick Facts
Valuation
$4.2B
Latest Round Size
$700M
Latest Round Date
February 2024
Sana Biotechnology: IPO Funding Round
Sana Biotechnology has successfully raised $700M in IPO funding, reaching a valuation of $4.2B.
Company Overview
Cell and gene therapy platform
Funding Details
The IPO round was led by Flagship Pioneering, with participation from ARCH Venture Partners, F-Prime Capital, Baillie Gifford.
Company Information
- Headquarters: 188 East Blaine Street, Seattle, WA 98102
- Founded: 2018
- Employees: 400+
- Category: Biotech
Investment
Sana Biotechnology plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Flagship Pioneering: Verified investor in IPO
- ARCH Venture Partners: Verified investor in IPO
- F-Prime Capital: Verified investor in IPO
- Baillie Gifford: Verified investor in IPO
Key Investors
Flagship Pioneering
Lead Investor
Verified investor in IPO
ARCH Venture Partners
Investor
Verified investor in IPO
F-Prime Capital
Investor
Verified investor in IPO
Baillie Gifford
Investor
Verified investor in IPO
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min read•$250M